Your browser doesn't support javascript.
loading
Validation of the Arabic Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
Khalil, Hanan; Aldaajani, Zakiyah F; Aldughmi, Mayis; Al-Sharman, Alham; Mohammad, Tareq; Mehanna, Raja; El-Jaafary, Shaimaa I; Dahshan, Ahmed; Ben Djebara, Mouna; Kamel, Walaa A; Amer, Hanan A; Farghal, Mohammed; Abdulla, Fatema; Al-Talai, Nouf; Snineh, Muneer Abu; Farhat, Nouha; Jamali, Fatima A; Matar, Rawan K; Abdelraheem, Heba S; Ghonimi, Nesma A M; Al-Melh, Mishal Abu; Elbhrawy, Sonia; Alotaibi, Majid S; Elaidy, Shaimaa A; Almuammar, Shahad A; Al-Hashel, Jasem Y; Gouider, Riadh; Samir, Hatem; Mhiri, Chokri; Skorvanek, Matej; Lin, Jeffrey; Martinez-Martin, Pablo; Stebbins, Glenn T; Luo, Sheng; Goetz, Christopher G; Bajwa, Jawad A.
Affiliation
  • Khalil H; Department of Physical Therapy and Rehabilitation Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
  • Aldaajani ZF; Faculty of Applied Medical Sciences, Department of Rehabilitation Sciences, Jordan University of Science and Technology, Irbid, Jordan.
  • Aldughmi M; Neurology Unit, King Fahad Medical Military Complex, Dhahran, Saudi Arabia.
  • Al-Sharman A; Department of Physiotherapy, School of Rehabilitation Sciences, University of Jordan, Amman, Jordan.
  • Mohammad T; Faculty of Applied Medical Sciences, Department of Rehabilitation Sciences, Jordan University of Science and Technology, Irbid, Jordan.
  • Mehanna R; National Neuroscience Nursing Administration, Executive Administration of Nursing Affairs, Riyadh, Saudi Arabia.
  • El-Jaafary SI; University of Texas Health Science Center at Houston - McGovern Medical School, Houston, Texas, USA.
  • Dahshan A; Neurology Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt.
  • Ben Djebara M; Neurology Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt.
  • Kamel WA; Department of Neurology, Clinical Investigation Center - Razi University Hospital, Faculté de Médecine de Tunis, Université Tunis El Manar, Tunis, Tunisia.
  • Amer HA; Neurology department, Beni-Suef University, Egypt.
  • Farghal M; Neurology Department- Ibn Sina Hospital, Kuwait City, Kuwait.
  • Abdulla F; Neurology Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt.
  • Al-Talai N; Neurology Division, Al-Adan Hospital, Kuwait City, Kuwait.
  • Snineh MA; Clinical Neuroscience Department, Salmaniya Medical Complex, Manama, Bahrain.
  • Farhat N; Neurology Department, Rashid Hospital, Dubai, UAE.
  • Jamali FA; Neurology Department, Hadassah Hospital, Jerusalem, Israel.
  • Matar RK; Department of Neurology, Clinical Investigation Center - Habib Bourguiba Hospital University Center, Sfax, Tunisia.
  • Abdelraheem HS; Cell Therapy Center, University of Jordan, Amman, Jordan.
  • Ghonimi NAM; Clinical Neuroscience Department, Salmaniya Medical Complex, Manama, Bahrain.
  • Al-Melh MA; Department of Neurology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Elbhrawy S; Department of Neurology, Zagazig University, Zagazig, Egypt.
  • Alotaibi MS; Neurology Division, Al-Adan Hospital, Kuwait City, Kuwait.
  • Elaidy SA; Department of Neurology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Almuammar SA; Neuroscience Centre, King Fahd Specialist Hospital, Dammam, Saudi Arabia.
  • Al-Hashel JY; Department of Neurology, Zagazig University, Zagazig, Egypt.
  • Gouider R; Neuroscience Centre, King Fahd Specialist Hospital, Dammam, Saudi Arabia.
  • Samir H; Neurology Department- Ibn Sina Hospital, Kuwait City, Kuwait.
  • Mhiri C; Department of Neurology, Clinical Investigation Center - Razi Hospital, Faculté de Médecine de Tunis, Tunis El Manar University, Tunis, Tunisia.
  • Skorvanek M; Neurology Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt.
  • Lin J; Department of Neurology, Clinical Investigation Center - Habib Bourguiba Hospital University Center, Sfax, Tunisia.
  • Martinez-Martin P; Department of Neurology, P. J. Safarik University, Kosice, Kosice, Slovak Republic.
  • Stebbins GT; Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic.
  • Luo S; Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Goetz CG; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain.
  • Bajwa JA; Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Mov Disord ; 37(4): 826-841, 2022 04.
Article in En | MEDLINE | ID: mdl-35218056
ABSTRACT

BACKGROUND:

The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) has become the gold standard for evaluating different domains in Parkinson's disease (PD), and it is commonly used in clinical practice, research, and clinical trials.

OBJECTIVES:

The objectives are to validate the Arabic-translated version of the MDS-UPDRS and to assess its factor structure compared with the English version.

METHODS:

The study was carried out in three phases first, the English version of the MDS-UPDRS was translated into Arabic and subsequently back-translated into English by independent translation team; second, cognitive pretesting of selected items was performed; third, the Arabic version was tested in over 400 native Arabic-speaking PD patients. The psychometric properties of the translated version were analyzed using confirmatory factor analysis (CFA) as well as exploratory factor analysis (EFA).

RESULTS:

The factor structure of the Arabic version was consistent with that of the English version based on the high CFIs for all four parts of the MDS-UPDRS in the CFA (CFI ≥0.90), confirming its suitability for use in Arabic.

CONCLUSIONS:

The Arabic version of the MDS-UPDRS has good construct validity in Arabic-speaking patients with PD and has been thereby designated as an official MDS-UPDRS version. The data collection methodology among Arabic-speaking countries across two continents of Asia and Africa provides a roadmap for validating additional MDS rating scale initiatives and is strong evidence that underserved regions can be energically mobilized to promote efforts that apply to better clinical care, education, and research for PD. © 2022 International Parkinson and Movement Disorder Society.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: Qatar

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: Qatar